Are all prostate cancer patients "fit" for salvage radiotherapy?

The indication for salvage radiotherapy (RT) (SRT) in patients with biochemically-recurrent prostate cancer after surgery is based on prostate-specific antigen (PSA) levels at the time of biochemical recurrence. Although there are clear criteria (pT3-pT4 disease and/or positive margins) for the use...

Descripción completa

Detalles Bibliográficos
Autores principales: González-San Segundo, Carmen, Gómez-Iturriaga, Alfonso, Couñago, Felipe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935690/
https://www.ncbi.nlm.nih.gov/pubmed/31976305
http://dx.doi.org/10.5306/wjco.v11.i1.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935690/
https://www.ncbi.nlm.nih.gov/pubmed/31976305
http://dx.doi.org/10.5306/wjco.v11.i1.1

Ejemplares similares